Cuorips Inc

TSE • Healthcare • Biotechnology • Quote as of 10/28/2026 14:34

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeTSE

Market Capitalization55,756 mln

Float6.28 mln

Earnings Date05/14/2025

Piotroski F-Score

2 / 9

Weak

Beneish M-Score

-2.22

Caution advised

Relative Strength

99 / 100

Top performer

Pre-Tax Margin

-893%

Severely loss-making

ROE

-22.93

Deeply negative

Altman Z-Score

98.79

Exceptional

Business Description

Cuorips Inc. is a Tokyo-based company founded in 2017 that develops and sells heart muscle tissue grown from human stem cells. The company also manufactures cell-based products and offers contract development, manufacturing, and consulting services to clients in the life sciences field.

Key Fundamentals

EPS-138

ROE-22.93

RPS15.53

ROIC-96.53

ROA-21.62

EBITDA, mln-1,052

EV / EBITDA-52.90

EV / EBIT-48.47

Revenue, mln129

EV / Revenue433

Quote Details

Last 7,340.00

Change 290 (4.11%)

Open 7,040.00

Volume 231,300

Turnover 1,697,741,952

Average Volume 202,214

Financial Ratios

Pre-Tax Profit Margin-893

Leverage Ratio1.08

Current Ratio16.26

Price / Book12.30

Price / Tangible Book12.64

Price / Sales424

Financial Strength

Altman Z-Score98.79

Piotroski F-Score 2 / 9

Beneish M-Score-2.22

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	4.86%	96 / 100
1 Month	28.1%	99 / 100
2 Months	62.93%	99 / 100
6 Months	4.26%	62 / 100
1 Year	9.72%	51 / 100